Rhino Ventures

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Klue is a B2B SaaS company that specializes in market and competitive intelligence, founded in 2015 by Jason Smith and Sarathy Naicker, and is based in Vancouver, Canada. The company offers a competitive enablement platform that assists sales and revenue teams in utilizing competitive intelligence to enhance their business outcomes. Klue's platform aggregates and organizes intelligence from various internal and external sources, providing actionable insights that help organizations navigate competitive environments effectively. By leveraging this curated intelligence, businesses can make informed decisions and improve their competitive positioning in the market.

Klue is a B2B SaaS company that specializes in market and competitive intelligence, founded in 2015 by Jason Smith and Sarathy Naicker, and is based in Vancouver, Canada. The company offers a competitive enablement platform that assists sales and revenue teams in utilizing competitive intelligence to enhance their business outcomes. Klue's platform aggregates and organizes intelligence from various internal and external sources, providing actionable insights that help organizations navigate competitive environments effectively. By leveraging this curated intelligence, businesses can make informed decisions and improve their competitive positioning in the market.

Curatio Networks Inc. is a Vancouver-based company that develops a mobile and desktop application known as Curatio, which provides a social health prescription solution for patients. This platform empowers individuals to create their own private support networks, allowing them to connect with peers and experts while accessing health trackers and sharing valuable information regarding their conditions. Curatio facilitates compliant engagement between patients and various stakeholders, including payers, providers, researchers, and pharmaceutical manufacturers, across 85 countries and in five languages. The platform's unique approach to fostering peer support and tailored health monitoring has earned it multiple awards, reinforcing its commitment to ensuring that no patient feels alone during their health journey.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Klue is a B2B SaaS company that specializes in market and competitive intelligence, founded in 2015 by Jason Smith and Sarathy Naicker, and is based in Vancouver, Canada. The company offers a competitive enablement platform that assists sales and revenue teams in utilizing competitive intelligence to enhance their business outcomes. Klue's platform aggregates and organizes intelligence from various internal and external sources, providing actionable insights that help organizations navigate competitive environments effectively. By leveraging this curated intelligence, businesses can make informed decisions and improve their competitive positioning in the market.

Askott Entertainment is a comprehensive development company that operates at the intersection of esports and regulated online gaming. Founded in 2014 and based in Vancouver, British Columbia, the company specializes in providing a robust iGaming platform known as Chameleon, aimed at engaging the esports and millennial demographics. Askott Entertainment's expertise encompasses all facets of the iGaming industry, including licensing, hosting, payments, security, and mobile solutions. By offering a range of services from project consultation to complete product development, the company positions itself as a full-service partner for clients seeking to navigate the complexities of the regulated gaming landscape.